DOCSLIB.ORG

Margin Stocks, Notice 97-22

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Margin Stocks, Notice 97-22 F e d e r a l R e s e r v e B a n k OF DALLAS ROBERT D. MCTEER, JR. _____ p r e s i d e n t DALLAS, TEXAS AND CHIEF EXECUTIVE OFFICER 75265-5906 March 10, 1997 Notice 97-22 TO: The Chief Executive Officer of each member bank and others concerned in the Eleventh Federal Reserve District SUBJECT Over-the-Counter (OTC) Margin Stocks DETAILS The Board of Governors of the Federal Reserve System has revised the list of over- the-counter (OTC) stocks that are subject to its margin regulations, effective February 10, 1997. Included with the list is a listing of foreign margin stocks that are subject to Regulation T. The foreign margin stocks listed are foreign equity securities eligible for margin treatment at broker- dealers. The Board publishes complete lists four times a year, and the Federal Register announces additions to and deletions from the lists. ATTACHMENTS Attached are the complete lists of OTC stocks and foreign margin stocks as of February 10, 1997. Please retain these lists, which supersede the complete lists published as of February 12, 1996. Announcements containing additions to and deletions from the lists will be provided quarterly. MORE INFORMATION For more information regarding marginable OTC stock requirements, please contact Eugene Coy at (214) 922-6201. For additional copies of this Bank's notice and the complete lists, please contact the Public Affairs Department at (214) 922-5254. Sincerely yours, yf f a * / ' . For additional copies, bankers and others are encouraged to use one of the following toll-free numbers in contacting the Federal Reserve Bank of Dallas: Dallas Office (800) 333 -4460; El Paso Branch Intrastate (800) 592-1631, Interstate (800) 351-1012; Houston Branch Intrastate (800) 392-4162, Interstate (800) 221-0363; San Antonio Branch Intrastate (800) 292-5810. This publication was digitized and made available by the Federal Reserve Bank of Dallas' Historical Library ([email protected]) List of Marginable OTC Stocks 1ST BANCORP (Indiana) ABC RAIL PRODUCTS CORPORATION ACMAT CORPORATION 51.00 par common $.01 par common Class A, no par common 1ST BERGEN BANCORP ABER RESOURCES LTD. ACRES GAMING INCORPORATED No par common No par common $.01 par common 1ST SOURCE CORPORATION ABIGAIL ADAMS NATIONAL BANCORP, INC. ACRODYNE COMMUNICATIONS, INC. 51.00 par common $.01 par common $.01 par common 1ST UNITED BANCORP (Florida) ABINGTON SAVINGS BANK (Massachusetts) ACT MANUFACTURING, INC. 5.01 par common $.10 par common $.01 par common 3-D GEOPHYSICAL, INC. ABIOMED, INC. ACT NETWORKS, INC. 5.01 par common $.01 par common $.01 par common 3-D SYSTEMS CORPORATION ABLE TELCOM HOLDING CORPORATION ACTEL CORPORATION 5.001 par common $.001 par common $.001 par common 3COM CORPORATION ABR INFORMATION SERVICES INC. ACTION PERFORMANCE COMPANIES, INC. No par common $.01 par common $.01 par common t3 D LABS INC. LIMITED ABRAMS INDUSTRIES, INC. ACTIVE APPAREL GROUP, INC. $.01 par common $1.00 par common $.002 par common 3DO COMPANY. THE ABRAXAS PETROLEUM CORPORATION ACTIVE VOICE CORPORATION 5.01 par common $.01 par common No par common t3D X TECHNOLOGIES. INC. ABT BUILDING PRODUCTS CORPORATION ACTIVISION, INC. 5.01 par common $.01 par common $.0001 par common 4 KIDS ENTERTAINMENT. INC. ACACIA RESEARCH CORPORATION tACTRADE INTERNATIONAL, LTD. 5.01 par common No par common $.001 par common 4FRONT SOFTWARE INTERNATIONAL. INC. ACC CONSUMER FINANCE CORPORATION ACXIOM CORPORATION No par common $.001 par common $.10 par common 4HEALTH. INC. ACC CORPORATION ADAC LABORATORIES 5.01 par common $.015 par common No par common Warrants (expire 01-15-98) ACCEL INTERNATIONAL CORPORATION ADAGE, INC. 7TH LEVEL. INC. $.10 par common $.60 par common 5.01 par common 1-ACCELR8 TECHNOLOGY CORPORATION ADAPTEC, INC. A B ELECTROLUX No par common $.001 par common Class B. American Depositary Receipts tACCENT COLOR SCIENCES, INC. ADAPTIVE SOLUTIONS, INC, A.D.A.M. SOFTWARE, INC. No par common No par common 5.01 par common ACCENT SOFTWARE INTERNATIONAL ADC TELECOMMUNICATIONS, INC. A.S.V., INC. Ordinary Shares par NIS .01 $.20 par common 5.01 par common ACCESS ANYTIME BANCORP, INC. ADCO TECHNOLOGIES, INC. $.01 par common AAON, INC. $.01 par common 5.001 par common tACCESS BEYOND, INC. ADE CORPORATION $.01 par common AARON RENTS, INC. $.01 par common 51.00 par common ACCESS HEALTH, INC. S.50 par common ADECCO S.A. $.001 par common American Depositary Receipts AASCHE TRANSPORTATION SERVICES, INC. ACCLAIM ENTERTAINMENT, INC. 5.0001 par common $.02 par common ADELPHIA COMMUNICATIONS CORPORATION Warrants (expire 02-09-2000) Class A, $.01 par common ACCOM, INC. AAV ID 'I HERMAL TECHNOLOGIES, INC. $.001 par common ADEPT TECHNOLOGY, INC. 5.01 par common No par common ACCUGRAPH CORPORATION ABACAN RESOURCE CORPORATION Class A, No par common ADFLEX SOLUTIONS, INC. No par common $.01 par common ACCUMED INTERNATIONAL, INC. ABACUS DIRECT CORPORATION No par common ADIA S.A. 5.001 par common Warrants (expire 10-14-97) $.25 par common ABAXIS, INC. ACE CASH EXPRESS, INC. ADOBE SYSTEMS INCORPORATED No par common $.01 par common No par common ABC BANCORP (Georgia) ACE’COMM CORPORATION ADTRAN, INC. 51.00 par common $.01 par common $.01 par common ABC DISPENSING TECHNOLOGIES, INC. ACETO CORPORATION ADVANCE PARADIGM, INC. 5.01 par common S.01 par common $.01 par common 'Addition to List under Board criteria — 1 — tAddition to List under NMS designation ADVANCED AERODYNAMICS & STRUCTURES, AFFILIATED COMPUTER SERVICES, INC. ALEXION PHARMACEUTICALS, INC. INC. Class A, $.01 par common $.0001 par common t $.0001 par common t Class A, warrants (expire 12-03-2001) AFFINITY TECHNOLOGY GROUP, INC. ALFA CORPORATION t Class B, warrants (expire 12-03-2001) $.0001 par common $1.00 par common ADVANCED DEPOSITION TECHNOLOGIES, INC. AFFINITY TELEPRODUCTIONS, INC. ALGOMA STEEL, INC. $.01 par common $.01 par common No par common ALGOS PHARMACEUTICAL CORPORATION ADVANCED DIGITAL INFORMATION AFFYMETRIX, INC. $.01 par common CORPORATION No par common No par common AFSALA BANCORP, INC. (New York) ALIANT COMMUNICATIONS, INC. $.01 par common $.25 par common ADVANCED ENERGY INDUSTRIES, INC. $.001 par common tAFTERMARKET TECHNOLOGY CORPORATION ALICO, INC. $.01 par common $1.00 par common ADVANCED FIBRE COMMUNICATIONS $.01 par common AG ASSOCIATES, INC. ALIGN-RITE INTERNATIONAL, INC. No par common $.01 par common ADVANCED HEALTH CORPORATION $.01 par common AG-CHEM EQUIPMENT CO., INC. ALKERMES, INC. $.01 par common $.01 par common ADVANCED LIGHTING TECHNOLOGIES, INC. $.001 par common AGOURON PHARMACEUTICALS, INC. ALL AMERICAN COMMUNICATIONS, INC. No par common $.0001 par common ADVANCED LOGIC RESEARCH, INC. Class B, non-voting, $.0001 par common $.01 par common AGRI-NUTRITION GROUP LIMITED $.01 par common ALL AMERICAN SEMICONDUCTOR, INC. ADVANCED MARKETING SERVICES, INC. $.01 par common $.001 par common AHI HEALTHCARE SYSTEMS, INC. $.01 par common ALL-COMM MEDIA CORPORATION ADVANCED POLYMER SYSTEMS, INC. $.01 par common $.01 par common AIR CANADA CORPORATION Class A, non-voting par common ALLCITY INSURANCE COMPANY tADVANCED RADIO TELECOM CORPORATION $1.00 par common $.001 par common AIR EXPRESS INTERNATIONAL CORPORATION $.01 par common ALLEGIANT BANCORP, INC. ADVANCED TECHNOLOGY LABORATORIES, INC. $.01 par common $.01 par common AIR METHODS CORPORATION $.06 par common tALLEGRO NEW MEDIA, INC. ADVANCED TECHNOLOGY MATERIALS, INC. $.001 par common $.01 par common AIR-CURE TECHNOLOGIES, INC. $.01 par common ALLEN ORGAN COMPANY ADVANCED TISSUE SCIENCES, INC. Class B, $1.00 par common $.01 par common AIRNET SYSTEMS, INC. $.01 par common ALLERGAN LIGAND RETINOID THERAPEUTICS ADVANTA CORP. Units (expire 06-05-97) Class A, $.01 par common AIRPORT SYSTEMS INTERNATIONAL, INC. Class B, non-voting, $.01 par common $.01 par common ALLIANCE COMMUNICATIONS CORPORATION Depositary Shares Class B, non-voting, no par common AIRSENSORS, INC. ADVANTAGE BANCORP, INC. (Wisconsin) $.001 par common ALLIANCE GAMING CORPORATION $.01 par common Warrants (expire 11-07-97) $.10 par common Series B, 15% non-voting senior special stock ADVENT SOFTWARE, INC. AIRWAYS CORPORATION $.01 par common $.01 par common ALLIANCE PHARMACEUTICAL CORP. $.01 par common AJAY SPORTS, INC. AEGIS CONSUMER FUNDING GROUP, THE Series C, 10% par cumulative convertible ALLIANCE SEMICONDUCTOR CORPORATION $.01 par common preferred $.01 par common AEP INDUSTRIES, INC. AKORN, INC. ALLIED BANKSHARES, INC. (Georgia) $.01 par common No par common $1.00 par common AER ENERGY RESOURCES, INC. AKSYS, LTD. ALLIED CAPITAL ADVISERS, INC. No par common $.01 par common $.001 par common AERIAL COMMUNICATIONS, INC. AKZO NOBEL N.V. ALLIED CAPITAL COMMERCIAL CORPORATION $1.00 par common American Depositary Receipts $.0001 par common AEROVOX INCORPORATED ALABAMA NATIONAL BANCORPORATION ALLIED CAPITAL CORPORATION $1.00 par common $1.00 par common $1.00 par common AES CHINA GENERATING CO., LTD. ALADDIN KNOWLEDGE SYSTEMS LTD. ALLIED CAPITAL CORPORATION II Class A, $.01 par common Ordinary Shares, NIS .01 par value $1.00 par common AES CORPORATION, THE ALBANK FINANCIAL CORPORATION ALLIED CAPITAL LENDING CORPORATION Warrants expire 2001 $.01 par common $.0001 par common AETRIUM INCORPORATED ALCIDE CORPORATION ALLIED GROUP, INC. $.001 par common $.01 par common No par common AFC CABLE SYSTEMS, INC. ALDILA, INC. ALLIED HEALTHCARE PRODUCTS, INC. $.01 par common $.01 par common $.01 par common AFFILIATED COMMUNITY BANCORP, INC. ALEXANDER & BALDWIN, INC. ALLIED HOLDINGS INC. $.01 par common No par common No par common 'Addition to List under Board criteria — 2 — tAddition to List
Load more

Recommended publications
  • Communisis Plc Coverage Initiated: 02 June 2014 Ticker: LSE:CMS This Document: 5 May 2015 Headquarters: London, U.K
    Due Diligence and Valuation Report Arrowhead Code: 64-01-02 Company: Communisis plc Coverage initiated: 02 June 2014 Ticker: LSE:CMS This document: 5 May 2015 Headquarters: London, U.K. Fair share value bracket (DCF): £0.66 and £0.84 Chairman: Mr. Peter Hickson Share price (1 May 15): £0.57i CEO: Mr. Andy Blundell Analysts S&C Development Director: Mr. Nigel Howes Snehal Mahajan Finance Director: Mr. Mark Stoner [email protected] Website: www.communisis.com +1 (212) 619-6889 Market Data Multi-Channel Diversified Offerings And Relentless 52-Week Range: £0.47 - £0.70ii Focus On Acquiring New Contracts To Fuel Growth Average Daily Volume (3M): 385,266iii Arrowhead is initiating coverage on Communisis plc with Market Cap. (01 May 15): £117.2 MM a fair value bracket of £0.66 (Low-Bracket estimate) and £0.84 (High-Bracket estimate). Financial Forecast (in £) (FY ending - Dec) Key Highlights: (1) Client confidence in Communisis’ '15E '16E '17E ‘18E ‘19E ‘20E '21E quality of service offerings, as evidenced by the High NI 9.48 12.52 14.55 16.82 18.84 18.91 20.70 Company’s track record of consistently winning large and £ MM long-term contracts from blue-chip firms such as LBG, High EPS* 5.95 7.05 8.14 9.07 9.95 9.98 10.82 Low NI AXA UK, Nationwide Building Society (NBS), and Proctor 6.14 8.45 11.01 13.38 14.30 14.61 16.18 £ MM & Gamble (P&G); (2) Communisis through its diversified Low EPS* 4.38 5.14 6.48 7.46 7.82 7.96 8.70 service offerings positions itself as a perfect partner to *Adjusted Diluted EPS in pence provide communication more effectively and profitably Company Overview: Based in London, Communisis plc across multiple channels; (3) Communisis is well- (hereafter referred to as “Communisis” or “the Company”) positioned to take advantage of the growing preference is a leading multi-channel customer communication for digital marketing; (4) The Company has access to services provider with expertise in transactional, market leading technology and has successfully deployed marketing, and regulatory communications.
    [Show full text]
  • List of Marginable OTC Stocks
    List of Marginable OTC Stocks @ENTERTAINMENT, INC. ABACAN RESOURCE CORPORATION ACE CASH EXPRESS, INC. $.01 par common No par common $.01 par common 1ST BANCORP (Indiana) ABACUS DIRECT CORPORATION ACE*COMM CORPORATION $1.00 par common $.001 par common $.01 par common 1ST BERGEN BANCORP ABAXIS, INC. ACETO CORPORATION No par common No par common $.01 par common 1ST SOURCE CORPORATION ABC BANCORP (Georgia) ACMAT CORPORATION $1.00 par common $1.00 par common Class A, no par common Fixed rate cumulative trust preferred securities of 1st Source Capital ABC DISPENSING TECHNOLOGIES, INC. ACORN PRODUCTS, INC. Floating rate cumulative trust preferred $.01 par common $.001 par common securities of 1st Source ABC RAIL PRODUCTS CORPORATION ACRES GAMING INCORPORATED 3-D GEOPHYSICAL, INC. $.01 par common $.01 par common $.01 par common ABER RESOURCES LTD. ACRODYNE COMMUNICATIONS, INC. 3-D SYSTEMS CORPORATION No par common $.01 par common $.001 par common ABIGAIL ADAMS NATIONAL BANCORP, INC. †ACSYS, INC. 3COM CORPORATION $.01 par common No par common No par common ABINGTON BANCORP, INC. (Massachusetts) ACT MANUFACTURING, INC. 3D LABS INC. LIMITED $.10 par common $.01 par common $.01 par common ABIOMED, INC. ACT NETWORKS, INC. 3DFX INTERACTIVE, INC. $.01 par common $.01 par common No par common ABLE TELCOM HOLDING CORPORATION ACT TELECONFERENCING, INC. 3DO COMPANY, THE $.001 par common No par common $.01 par common ABR INFORMATION SERVICES INC. ACTEL CORPORATION 3DX TECHNOLOGIES, INC. $.01 par common $.001 par common $.01 par common ABRAMS INDUSTRIES, INC. ACTION PERFORMANCE COMPANIES, INC. 4 KIDS ENTERTAINMENT, INC. $1.00 par common $.01 par common $.01 par common 4FRONT TECHNOLOGIES, INC.
    [Show full text]
  • Public Plicy Brief 44
    PPB No.44 2/18/99 2:50 PM Page a1 The Jerome Levy Economics Institute of Bard College Public Policy Brief The Asian Disease: Pl a u s i b l e Di a g n o s e s , Po s s i b l e Re m e d i e s Regulation of Cros s - B o r der Interbank Lending and Derivatives Tra d e Ma r tin Mayer No. 44, 1998 PPB No.44 2/18/99 2:50 PM Page 2 The Jerome Levy Economics Institute of Bard Co l l e g e , founded in 1986, is an autonomous, inde- pendently endowed re s e a rch organization. It is n o n p a rtisan, open to the examination of diverse points of view, and dedicated to public servi c e . The Jerome Levy Economics Institute is publish - ing this proposal with the conviction that it rep r e - sents a constructive and positive contribution to the discussions and debates on the relevant policy issues. Neither the Institute’s Board of Governo r s nor its Advisory Board necessarily endorses the pr oposal in this issue. The Levy Institute believes in the potential for the study of economics to improve the human condi- tion. Through scholarship and economic forecast- ing it generates viable, effective public policy responses to important economic problems that profoundly affect the quality of life in the United States and abroad. The present res e a r ch agenda includes such issues as financial instability, povert y, employment, pro b- lems associated with the distribution of income and wealth, and international trade and competitive- ness.
    [Show full text]
  • Tuesday July 30, 1996
    7±30±96 Tuesday Vol. 61 No. 147 July 30, 1996 Pages 39555±39838 federal register 1 II Federal Register / Vol. 61, No. 147 / Tuesday, July 30, 1996 SUBSCRIPTIONS AND COPIES PUBLIC Subscriptions: Paper or fiche 202±512±1800 FEDERAL REGISTER Published daily, Monday through Friday, Assistance with public subscriptions 512±1806 (not published on Saturdays, Sundays, or on official holidays), by General online information 202±512±1530 the Office of the Federal Register, National Archives and Records Administration, Washington, DC 20408, under the Federal Register Single copies/back copies: Act (49 Stat. 500, as amended; 44 U.S.C. Ch. 15) and the Paper or fiche 512±1800 regulations of the Administrative Committee of the Federal Register Assistance with public single copies 512±1803 (1 CFR Ch. I). Distribution is made only by the Superintendent of Documents, U.S. Government Printing Office, Washington, DC FEDERAL AGENCIES 20402. Subscriptions: The Federal Register provides a uniform system for making Paper or fiche 523±5243 available to the public regulations and legal notices issued by Assistance with Federal agency subscriptions 523±5243 Federal agencies. These include Presidential proclamations and For other telephone numbers, see the Reader Aids section Executive Orders and Federal agency documents having general applicability and legal effect, documents required to be published at the end of this issue. by act of Congress and other Federal agency documents of public interest. Documents are on file for public inspection in the Office of the Federal Register the day before they are published, unless earlier filing is requested by the issuing agency.
    [Show full text]
  • The Reason Given for the UK's Decision to Float Sterling Was the Weight of International Short-Term Capital
    - Issue No. 181 No. 190, July 6, 1972 The Pound Afloat: The reason given for the U.K.'s decision to float sterling was the weight of international short-term capital movements which, despite concerted intervention from the Bank of England and European central banks, had necessitated massive sup­ port operations. The U.K. is anxious that the rate should quickly o.s move to a "realistic" level, at or around the old parity of %2. 40 - r,/, .• representing an effective 8% devaluation against the dollar. A w formal devaluation coupled with a wage freeze was urged by the :,I' Bank of England, but this would be politically embarrassing in the }t!IJ light of the U.K. Chancellor's repeated statements that the pound was "not at an unrealistic rate." The decision to float has been taken in spite of a danger that this may provoke an international or European monetary crisis. European markets tend to consider sterling as the dollar's first line of defense and, although the U.S. Treasury reaffirmed the Smithsonian Agreement, there are fears throughout Europe that pressure on the U.S. currency could disrupt the exchange rate re­ lationship established last December. On the Continent, the Dutch and Belgians have put forward a scheme for a joint float of Common Market currencies against the dollar. It will not easily be implemented, since speculation in the ex­ change markets has pushed the various EEC countries in different directions. The Germans have been under pressure to revalue, the Italians to devalue. Total opposition to a Community float is ex­ pected from France (this would sever the ties between the franc and gold), and the French also are adamant that Britain should re­ affirm its allegiance to the European monetary agreement and return to a fixed parity.
    [Show full text]
  • Health Industry Business Communications Council
    Health Industry Business Communications Council Registered Labelers: Accredited Auto-ID Labeling Standards Argentina New MedTek Devices Pty Ltd Oxavita SRL Norseld Pty Ltd. Novadien Healthcare Pty Ltd The following companies Odontit S.A. (and/or their subsidiaries/ PAMPAMED S.R.L. Numedico Technologies Pty Ltd divisions) have applied PATEJIM SRL Opto Global Pty. Ltd. for a Labeler Identification Orthocell Limited Code (LIC) assignment with Austria Prolotus Technologies Pty Ltd HIBCC*. By doing so, they afreeze GmbH Red Milawa Pty Ltd dba Magic Mobility have demonstrated their AMI GmbH SDI Limited commitment to patient safety Bender Medsystems GmbH Signostics Ltd. and logistical efficiency for BHS Technologies GmbH Sirtex Medical Pty Ltd their customers, the industry Metasys Medizintechnik GmbH Smith & Nephew Surgical Pty. Ltd. and the public at large. PAA Laboratories GmbH Staminalift International Limited Safersonic Medizinprodukte Handels The Pipette Company Pty. Ltd. Any organization that is GmbH Thermo Electron Corporation interested in using the HIBC W & H Dentalwerk Burmoos GmbH Vush Pty Ltd uniform labeling system may apply for the assignment of VUSH STIMULATION Australia one or more LICs. William A Cook Australia Pty. Ltd. Adv. Surgical Design & Manufacture, Ltd. Last updated 9-21-2021 AirPhysio Pty Ltd Belgium Annalise-AI Pty Ltd 3M Europe Apollo Medical Imaging Technology Pty Advanced Medical Diagnostics SA/NV Ltd Analis SA/NV Benra Pty Ltd dba Gelflex Laboratories Baxter World Trade Bioclone Australia Pty. Ltd. Bio-Rad RSL Candelis, Inc. Bio-Rad Lab Inc Clinical Diag. Group DePuy Australia Pty. Ltd. Biosource Europe SA For more information, please dorsaVi Ltd Cilag NV contact the HIBCC office at: EC Certification Service GmbH Coris Bioconcept Fink Engineering Pty Ltd Fuji Hunt Photographic Chemicals NV 2525 E.
    [Show full text]
  • The Mixed Brand and Private Label Strategy – Retailer's Perspective
    The Mixed Brand and Private Label Strategy – Retailer’s Perspective illustrated by the Rema1000 case Jesper Kolind (WORK IN PROGRESS) Jesper Kolind is ph.d. student at the University of Southern Denmark, Department of Entrepreneurship and Relationship Management, Engstien 1, 6000 Kolding, Denmark E‐mail: [email protected] Page 1 Abstract In this paper, the terms “Focused” and “Mixed” suppliers / retailers are introduced and presented in an interface model. The general thesis is that suppliers and retailers face similar challenges and difficulties strategically and organizationally when they work with a mixed brand and private label strategy (working with both brands and private label in the same organization). Different models have been used with different results and the success/failure is not only a result of the individual approach but moreover of the co‐operation between the two parties. This paper is limited to the retailers perspective and is covered through a literature review in particular about the reasons for retailers to get involved in private label and illustrated by an explorative case study of the discounter Rema1000. Keywords: Retailers, suppliers, private label, interactions, dyads Introduction The last 10 years, I have been directly involved in selling private label products both in a company dominated by branded sales where private label had low priority but also in a private label dominated company where the priorities were opposite. During this period I have often experienced how difficult it is for the suppliers to balance the strategic focus between brands and private label. Likewise, I have experienced that retailers face the same strategic and organizational difficulties when it comes to a mixed strategy involving both brands and private labels.
    [Show full text]
  • Coordination Des Syndicats CGT
    Coordination des syndicats CGT STRATEGIE DE LA DIRECTION DU GROUPE SANOFI CONSEQUENCES INDUSTRIELLES ET SOCIALES Document d’août 2014 1. Situation économique – Coût du capital p2 2. Evolution des effectifs – Bilan des restructurations majeures p3 3. Stratégie Sanofi 2009-2015 : Désengagement scientifique et industriel en Europe et plus particulièrement en France p4 4. Stratégie de structuration du groupe en entités qui peuvent être cédées, vendues, fermées, échangées. p6 5. Crédit d’impôt – Des aides publiques pour quel usage ? p7 6. Industrie pharmaceutique : des besoins fondamentaux p7 7. Interpellation des élus et du gouvernement p8 1. Situation économique – Coût du capital Première entreprise pharmaceutique française et européenne. Sanofi est issu de la fusion de nombreux laboratoires pharmaceutiques français dont les principaux étaient Roussel Uclaf, Rhône Poulenc, Synthelabo, Sanofi et de l’allemand Hoechst. Sanofi représente 30 à 40% du potentiel national (effectifs, sites, R&D,…) de l’industrie pharmaceutique française dans notre pays. L’avenir du groupe et de ses activités en France conditionne l’avenir de l’industrie pharmaceutique française et constitue un élément incontournable de l’indépendance thérapeutique du pays. Le C.A. de sanofi dans le monde sur 2013 a atteint 33 milliards € et devrait se situer à un niveau légèrement supérieur en 2014. Plusieurs médicaments de référence étant aujourd’hui tombés dans le domaine public, le chiffre d’affaires repart à la hausse. Le résultat net des activités a été de 6,8 milliards € en 2013 et les projections sur 2014 laissent envisager une progression de 5% de celui-ci. La rentabilité est estimée par les économistes parmi les meilleures de l’industrie pharmaceutique dans le monde.
    [Show full text]
  • NASD Notice to Members 98-47
    Executive Summary Interpretive Material 2310-3 (IM-2310- NASD On May 29, 1998, the Securities and 3) describes members’ suitability obli- Exchange Commission (SEC) gation in making recommendations to approved amendments to National institutional customers. The primary Notice to Association of Securities Dealers, considerations under IM-2310-3 Inc. (NASD®) Rule 3110 (the Books include the customer’s capability to and Records Rule) that (i) change evaluate risk independently and the Members the definition of “institutional account” extent to which individual judgment is to include the accounts of investment exercised when making investment 98-47 advisers that are now required to decisions. register with the states pursuant to the National Securities Markets Accounts Of Registered Improvement Act of 1996 (NSMIA), Investment Advisers and (ii) exclude certain customer SEC Approves Changes accounts from the requirement to NSMIA and new rules recently To Books And Records obtain certain tax and employment adopted by the SEC under the Requirements information from the customer. Investment Advisers Act of 1940 (Advisers Act) reallocated regulatory Questions concerning this Notice oversight of investment advisers may be directed to Joseph E. Price, between the SEC and the states. Counsel, Advertising/Investment Under the new rules, advisers to reg- Suggested Routing Companies Regulation, NASD Regu- istered investment companies and Senior Management lation, Inc., at (202) 728-8877 or those with assets under manage- Robert J. Smith, Assistant General ment of at least $25 million generally Advertising Counsel, Office of General Counsel, will register exclusively with the SEC. Continuing Education NASD RegulationSM, at (202) 728- Most others will register exclusively 8176.
    [Show full text]
  • 220648581.Pdf
    • LIST OF MARGINABLE OTC STOCKS 1 AND LIST OF FOREIGN MARGIN STOCKS 2 AS OF • November 12, 1996 • The List of Marginable OTC Stocks and the List of Foreign Margin Stocks are published quarterly by the Board of Governors of the Federal Reserve System (the Board). I. The List of Marginable OTC Stocks is composed of stocks traded in the United States over-the-counter (OTC) that have been determined by the Board to be subject to margin requirements as of November 12, 1996, pursuant to Section 207.6 of Federal Reserve Regulation G, "Securities Credit by Persons Other Than Banks, Brokers, or Dealers," Section 220.17 of Regulation T, "Credit by Brokers and Dealers," and Section 221.7 of Regulation U, "Credit by Banks for the Purpose of Purchasing or Carrying Margin Stocks." It also includes all OTC stocks designated as National Market • System (NMS) securities. Additional NMS securities may be added in the interim between Board quarterly publications; these securities are immediately marginable upon designation as NMS securities. The names of these securities are available at the National Association of Securities Dealers, Inc. and at the Securities and Exchange Commission. This List supersedes the previous List of Marginable OTC Stocks published effective August 12, 1996 . • The List of Foreign Margin Stocks is composed of foreign equity securities that have met the Board's eligibility criteria, pursuant to Regulation T, Section 220.17. These foreign equity securities are eligible for margin treatment at broker-dealers on the same basis as domestic margin securities. This list supersedes the previous List of Foreign Margin Stocks published effective August 12, 1996.
    [Show full text]
  • Delisted Companies 1999
    THE 1999 ASX DELISTED COMPANIES BOOK 1929 TO 1999 70 YEARS OF DELISTINGS Published by: Australian Stock Exchange Limited ACN 008 624 691 Level 7, Riverside Centre, 123 Eagle Street, Brisbane QLD 4000 Telephone 61 7 3835 4000 Facsimile 61 7 3835 4141 © Copyright Australian Stock Exchange Limited - 1999 All rights reserved. No part of this publication may be photocopied, reproduced, stored in a retrieval system, or transmitted in any form or by any means whether electronic, mechanical or otherwise, without prior written permission of the publisher. Enquiries should be addressed to The National Manager - Market Data, Australian Stock Exchange Limited. Australian Stock Exchange Limited (“ASX”)believes that all information contained in this publication is accurate and reliable. The information has been sourced from company reports and announcements lodged with Australian Stock Exchange Limited by each corporation. The information does not contain recommendations, reports, analysis, or other advisor information relating to specific securities or issuers of securities and does not constitute an invitation to persons to enter or offer to enter into an investment agreement or to exercise any rights conferred by an investment, to acquire, dispose of, underwrite or convert an investment. ASX, its related companies, their officers and employees shall not be liable in any way for any loss or damage, howsoever arising (whether in negligence or otherwise) out of or in connection with the contents of and/or any omissions from this publication except where a liability is made non-excludable by legislation. NAME CHANGE CROSS REFERENCE FOR DELISTED COMPANIES New Name Old Name Date A.F.M.
    [Show full text]
  • I4i Makes the Patent World Blind Michael J
    COMMENTS i4i Makes the Patent World Blind Michael J. Conway† All patents receive a presumption of validity pursuant to 35 USC § 282. Courts have traditionally put this presumption into practice by requiring inva- lidity to be established by clear and convincing evidence. The Supreme Court reaffirmed this understanding of the presumption in Microsoft Corp v i4i Ltd Partnership. District courts have divided, however, on whether to require clear and con- vincing evidence when the challenger seeks to invalidate a patent for covering inel- igible subject matter. The conflict originates from a concurrence written by Justice Stephen Breyer in i4i, in which he stated that a heightened standard of proof—like the clear and convincing standard—can apply only to issues of fact, not issues of law. Because subject-matter eligibility has traditionally presented an issue of law, some courts hold that subject-matter-eligibility challenges cannot be subjected to the clear and convincing standard. Other courts agree with that sentiment but would apply the clear and convincing standard to resolve any underlying issues of fact. Still others maintain that subject-matter-eligibility challenges must be estab- lished by clear and convincing evidence. This Comment resolves this ambiguity by showing that subject-matter- eligibility challenges must be established by clear and convincing evidence. It com- pares subject-matter-eligibility challenges to two other patent validity challenges: the on-sale bar and nonobviousness. These two comparisons show that patent law has consistently failed to confine the clear and convincing standard to issues of law. In fact, the standard has been imposed without regard for the distinction be- tween issues of law and fact.
    [Show full text]